Magnetar Financial’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-375,546
| Closed | -$1.54M | – | 1984 |
|
|
2022
Q1 | $1.54M | Sell |
375,546
-1,379,754
| -79% | -$5.66M | 0.02% | 718 |
|
|
2021
Q4 | $6.27M | Buy |
1,755,300
+882,324
| +101% | +$3.15M | 0.06% | 308 |
|
|
2021
Q3 | $3.18M | Buy |
872,976
+548,754
| +169% | +$2M | 0.03% | 509 |
|
|
2021
Q2 | $1.41K | Buy |
324,222
+138,327
| +74% | +$603 | 0.01% | 649 |
|
|
2021
Q1 | $764K | Sell |
185,895
-2,682
| -1% | -$11K | 0.01% | 740 |
|
|
2020
Q4 | $752K | Buy |
188,577
+6,471
| +4% | +$25.8K | 0.01% | 517 |
|
|
2020
Q3 | $492K | Buy |
182,106
+85,882
| +89% | +$232K | 0.01% | 447 |
|
|
2020
Q2 | $265K | Buy |
96,224
+17,644
| +22% | +$48.6K | 0.01% | 351 |
|
|
2020
Q1 | $185K | Buy |
+78,580
| New | +$185K | ﹤0.01% | 403 |
|